Adtalem Global Education (NYSE:CVSA) Announces Quarterly Earnings Results

Adtalem Global Education (NYSE:CVSA) issued its quarterly earnings data on Thursday. The company reported $2.09 earnings per share for the quarter, topping analysts’ consensus estimates of $1.90 by $0.19, FiscalAI reports. Adtalem Global Education had a return on equity of 20.19% and a net margin of 12.26%.The firm had revenue of $501.38 million for the quarter. Adtalem Global Education updated its FY 2027 guidance to 8.900-9.150 EPS.

Adtalem Global Education Stock Performance

Shares of CVSA opened at $125.10 on Friday. Adtalem Global Education has a fifty-two week low of $86.97 and a fifty-two week high of $156.26. The business has a 50-day simple moving average of $124.22. The stock has a market capitalization of $4.26 billion, a PE ratio of 19.49, a PEG ratio of 0.97 and a beta of 0.62. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.36.

Analyst Ratings Changes

Several brokerages have commented on CVSA. Wall Street Zen lowered shares of Adtalem Global Education from a “buy” rating to a “hold” rating in a report on Saturday, July 25th. Barrington Research reissued an “outperform” rating and issued a $170.00 target price on shares of Adtalem Global Education in a research report on Monday, June 8th. Truist Financial raised their target price on Adtalem Global Education from $130.00 to $140.00 and gave the company a “buy” rating in a research note on Monday, May 11th. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of Adtalem Global Education in a research report on Friday, May 22nd. Two research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $155.00.

Insider Transactions at Adtalem Global Education

In related news, SVP Douglas G. Beck sold 2,439 shares of the company’s stock in a transaction that occurred on Wednesday, July 8th. The stock was sold at an average price of $135.34, for a total value of $330,094.26. Following the sale, the senior vice president owned 33,070 shares in the company, valued at $4,475,693.80. This represents a 6.87% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Stephen W. Beard sold 2,529 shares of the firm’s stock in a transaction that occurred on Thursday, June 11th. The shares were sold at an average price of $130.78, for a total value of $330,742.62. Following the transaction, the chief executive officer directly owned 424,033 shares of the company’s stock, valued at approximately $55,455,035.74. This trade represents a 0.59% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 15,694 shares of company stock valued at $2,098,614 in the last ninety days. 2.50% of the stock is currently owned by corporate insiders.

About Adtalem Global Education

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.